Search Results 1621-1630 of 16903 for monoclonal antibody

  1. A Study to Compare Standard-Dose Combination Chemotherapy with High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Resistant Germ Cell Tumors - Mayo Clinic

    Hepatitis C antibody. No late relapse with completely surgically resectable disease; Patients with late relapses defined as relapse ≥ 2 years from the date ...

  2. Mechanisms of Astrocyte Reactivity - Translational Neuroimmunology Laboratory - Mayo Clinic Research

    Focus areas include: Discovering the mechanisms underlying astrocyte reactivity induced by the pathogenic antibody present in patients with neuromyelitis optica ...

  3. Infectious Diseases Clinical Trials - Mayo Clinic Research

    Phage, expressing melanoma cDNA express the proteins/peptides on their capsid are “recognized” by the immobilized antibodies are retained in ... Communities ...

  4. Hematology - Clinical trials

    The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

  5. Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome - Mayo Clinic

    - Absent or low patient donor-specific antibodies (DSA); - Mean fluorescence intensity (MFI) of any anti-donor HLA antibody by solid phase immunoassay ...

  6. A Study to Obtain Blood from Patients with Gammopathies - Mayo Clinic

    Any patient with monoclonal, biclonal or triclonal gammopathy. Exclusion Criteria: Patients with serious medical problems such as congestive heart failure ...

  7. Genetically Engineered Cells (MUC1-Activated T-Cells) for the Treatment of MUC1 Positive Recurrent or Refractory Multiple Myeloma - Mayo Clinic

    ... antibody. Patients must be at least 90 days since an autologous stem cell transplant, if performed. 3.1.5 Patients must have measurable disease per IMWG ...

  8. Lymphoma - Doctors and departments - Mayo Clinic

    Leif Bergsagel, M.D.. Internist; Oncologist. Phoenix, AZ. Areas of focus: Amyloidosis, Multiple myeloma, Waldenstrom macroglobulinemia, Monoclonal gammopathy of ...

  9. Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer - Mayo Clinic

    ... antibody (including ipilimumab or any other antibody or drug specifically targeting T-cell co-stimulation or checkpoint pathways). Prior treatment with ...

  10. A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma - Mayo Clinic

    Pathologically confirmed MCL, with documentation of monoclonal CD20+ B cells that have a chromosome translocation t(11;14)(q13;q32) and/or overexpress cyclin D1 ...